Gainers
- Mural Oncology (NASDAQ:MURA) shares increased by 31.1% to $1.35 during Tuesday's pre-market session. The company's market cap stands at $23.2 million.
- Ensysce Biosciences (NASDAQ:ENSC) stock rose 20.36% to $2.36. The company's market cap stands at $3.3 million.
- OneMedNet (NASDAQ:ONMD) shares rose 17.36% to $0.58. The market value of their outstanding shares is at $16.2 million.
- Fractyl Health (NASDAQ:GUTS) stock rose 15.61% to $1.15. The company's market cap stands at $55.3 million.
- MetaVia (NASDAQ:MTVA) shares increased by 14.13% to $2.1. The company's market cap stands at $18.1 million.
- Precision BioSciences (NASDAQ:DTIL) shares increased by 12.73% to $5.03. The company's market cap stands at $52.7 million.
Losers
- Elutia (NASDAQ:ELUT) shares fell 54.7% to $0.91 during Tuesday's pre-market session. The market value of their outstanding shares is at $37.1 million.
- Geovax Labs (NASDAQ:GOVX) shares decreased by 29.92% to $0.75. The company's market cap stands at $7.0 million.
- Spruce Biosciences (NASDAQ:SPRB) stock fell 23.35% to $0.24. The company's market cap stands at $9.9 million.
- Nexalin Technology (NASDAQ:NXL) stock fell 21.34% to $1.4. The market value of their outstanding shares is at $18.6 million.
- Longevity Health Holdings (NASDAQ:XAGE) shares decreased by 21.03% to $0.16. The market value of their outstanding shares is at $4.8 million.
- Sophia Genetics (NASDAQ:SOPH) stock decreased by 20.42% to $2.3. The company's market cap stands at $152.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ELUTElutia Inc
$0.71002.33%
ENSCEnsysce Biosciences Inc
$1.64-%
GOVXGeovax Labs Inc
$0.38010.80%
GUTSFractyl Health Inc
$2.050.25%
MTVAMetaVia Inc
$14.9883.1%
MURAMural Oncology PLC
$2.03-%
NXLNexalin Technology Inc
$1.025.14%
ONMDOneMedNet Corp
$1.77-%
SOPHSophia Genetics SA
$5.105.15%
SPRBSpruce Biosciences Inc
$80.000.01%
XAGELongevity Health Holdings Inc
$0.3892-83.2%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
